Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-03

FDA Approved: TELMISARTAN AND HYDROCHLOROTHIAZIDE — Original Application (Lifestar Pharma LLC)

View source ↗

Summary

The FDA approved a generic fixed-dose combination of telmisartan and hydrochlorothiazide (ANDA 218406) for hypertension, manufactured by Lifestar Pharma LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Telmisartan and Hydrochlorothiazide (telmisartan and hydrochlorothiazide)

Snippet

ORIG AP for TELMISARTAN AND HYDROCHLOROTHIAZIDE (TELMISARTAN AND HYDROCHLOROTHIAZIDE)